{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:22:05Z","timestamp":1790338925343,"version":"4.1.0"},"reference-count":0,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1997,8]]},"abstract":"<jats:p>Carbapenems L-749,345 and imipenem had the lowest MICs at which 90% of isolates were inhibited (0.5 microg\/ml) of 14 antimicrobial agents tested against 76 multiresistant gram-negative clinical isolates with TEM- or SHV-type extended-spectrum beta-lactamases and chromosomal or plasmid-determined AmpC beta-lactamases, but the MIC of L-749,345 for one isolate of Klebsiella pneumoniae was 16 microg\/ml.<\/jats:p>","DOI":"10.1128\/aac.41.8.1830","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:29:10Z","timestamp":1539044950000},"page":"1830-1831","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":41,"title":["Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens"],"prefix":"10.1128","volume":"41","author":[{"given":"G","family":"Jacoby","sequence":"first","affiliation":[{"name":"Lahey Hitchcock Clinic, Burlington, Massachusetts 01805, USA. George.A.Jacoby@Lahey.Hitchcock.Org"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Han","sequence":"additional","affiliation":[{"name":"Lahey Hitchcock Clinic, Burlington, Massachusetts 01805, USA. George.A.Jacoby@Lahey.Hitchcock.Org"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Tran","sequence":"additional","affiliation":[{"name":"Lahey Hitchcock Clinic, Burlington, Massachusetts 01805, USA. George.A.Jacoby@Lahey.Hitchcock.Org"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.41.8.1830","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.41.8.1830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:14:24Z","timestamp":1645474464000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.41.8.1830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["10.1128\/AAC.41.8.1830"],"URL":"https:\/\/doi.org\/10.1128\/aac.41.8.1830","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]},"assertion":[{"value":"1997-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}